Regado Biosciences
A company developing antithrombotic drug systems to treat acute and sub-acute cardiovascular and other indications
3
Funding Rounds
$114.0m
Money raised
Overview
A company developing antithrombotic drug systems to treat acute and sub-acute cardiovascular and other indications
- Website:
- Social accounts: facebook
Funding
Funding series
Funding Series Analysis
The company Regado Biosciences has raised a total of $114m in funding over 3 rounds.
Key Insights:
- Regado Biosciences Series E round: $51m
- Regado Biosciences Series D round: $40m
- Regado Biosciences Series C round: $23m
Regado Biosciences Series E round
$51m
Regado Biosciences Series D round
$40m
Regado Biosciences Series C round
$23m
Industries
Regado Biosciences is active in the following industries: